StocksVertex Pharmaceuticals IncorporatedVRTX

VRTX

Vertex Pharmaceuticals Incorporated

294.15 2.22 (0.76%)
Forsinkede priser fra NASDAQ, i USD Markedet stengt
Handle
S
294.15
K
294.80
Festet innlegg
Genome Engineering
Vertex, Verve team up to develop a gene editing drug for liver disease 🔹 $VRTX (Vertex Pharmaceuticals Incorporated) is broadening its reach in gene editing, announcing Wednesday a deal with $VERV (Verve Therapeutics Inc) to develop a one-time treatment for an undisclosed liver disease. Vertex will... Vis flere Oversett
Markedsfeed
Topp
Fabian Hermans
$VRTX (Vertex Pharmaceuticals Incorporated) The good news continues to flow. This month, the US Food and Drug Administration (FDA) lifted its clinical hold on VX-880. This is Vertex's treatment in development for type 1 diabetes (T1D) in a phase 1/2 clinical trial. The FDA had originally placed... Vis flere Oversett
VRTX
Vertex Pharmaceuticals Incorporated
294.15
2.22 (0.76%)
Handle
Leonidas Panagiotopoulos
@derek5858 It's time to say goodbye $VRTX (Vertex Pharmaceuticals Incorporated) . I believe the sector, but as usual, I like to sell near the all time highs. Closed with 40% profit. Oversett
Cancer-Med
Dear Investors, Here is your monthly update for July 2022. ✨ Financial markets rallied over the course of the month despite another 75 basis point rate hike from the U.S. Federal Reserve and the ongoing Russia-Ukraine conflict. China also continued to grapple with the Covid-19 pandemic, enforcing lockdowns... Vis flere Oversett
Genome Engineering
Dear Investors, Here is your monthly update for July 2022. ✨ Financial markets rallied over the course of the month despite another 75 basis point rate hike from the U.S. Federal Reserve and the ongoing Russia-Ukraine conflict. China also continued to grapple with the Covid-19 pandemic, enforcing lockdowns... Vis flere Oversett
MarketUpdates
Redigert
$VRTX (Vertex Pharmaceuticals Incorporated) Q3 2022-resultatrapport forventes publisert
1
NOV
RAPPORTER
Vertex Pharmaceuticals Incorporated Q3 2022 det forventes at inntektsrapporten publiseres etter at markedet åpner
Varsle meg
VRTX
VRTX
Vertex Pharmaceuticals Incorporated
294.15
2.22
(0.76%)
Handle
VRTX
Vertex Pharmaceuticals Incorporated
294.15
2.22 (0.76%)
Handle